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Groehs RV, Toschi-Dias E, Antunes-Correa LM, Trevizan PF, Ron-
don MU, Oliveira P, Alves MJ, Almeida DR, Middlekauff HR, Negrão
CE. Exercise training prevents the deterioration in the arterial baroreflex
control of sympathetic nerve activity in chronic heart failure patients. Am J
Physiol Heart Circ Physiol 308: H1096–H1102, 2015. First published
March 7, 2015; doi:10.1152/ajpheart.00723.2014.—Arterial baroreflex
control of muscle sympathetic nerve activity (ABRMSNA) is impaired
in chronic systolic heart failure (CHF). The purpose of the study was
to test the hypothesis that exercise training would improve the gain
and reduce the time delay of ABRMSNA in CHF patients. Twenty-six
CHF patients, New York Heart Association Functional Class II-III,
EF  40%, peak V˙ O2  20 ml·kg1·min1 were divided into two
groups: untrained (UT, n  13, 57  3 years) and exercise trained
(ET, n  13, 49  3 years). Muscle sympathetic nerve activity
(MSNA) was directly recorded by microneurography technique. Ar-
terial pressure was measured on a beat-to-beat basis. Time series of
MSNA and systolic arterial pressure were analyzed by autoregressive
spectral analysis. The gain and time delay of ABRMSNA was obtained
by bivariate autoregressive analysis. Exercise training was performed
on a cycle ergometer at moderate intensity, three 60-min sessions per
week for 16 wk. Baseline MSNA, gain and time delay of ABRMSNA,
and low frequency of MSNA (LFMSNA) to high-frequency ratio
(HFMSNA) (LFMSNA/HFMSNA) were similar between groups. ET sig-
nificantly decreased MSNA. MSNA was unchanged in the UT pa-
tients. The gain and time delay of ABRMSNA were unchanged in the
ET patients. In contrast, the gain of ABRMSNA was significantly
reduced [3.5  0.7 vs. 1.8  0.2, arbitrary units (au)/mmHg, P 
0.04] and the time delay of ABRMSNA was significantly increased (4.6
0.8 vs. 7.9 1.0 s, P 0.05) in the UT patients. LFMSNA-to-HFMSNA
ratio tended to be lower in the ET patients (P  0.08). Exercise
training prevents the deterioration of ABRMSNA in CHF patients.
chronic heart failure; sympathetic modulation; arterial baroreflex
control; exercise training
NEUROHUMORAL ACTIVATION is a marker in chronic systolic heart
failure (CHF). Muscle sympathetic nerve activity (MSNA) is
increased in moderate CHF patients compared with healthy
individuals (25). This increase in MSNA is even greater in
severe CHF patients (25), which suggests an association be-
tween sympathetic nerve activity and severity of heart failure.
Although the increase in sympathetic activity plays an im-
portant role in the initial and compensatory phase of the cardiac
dysfunction, its maintenance contributes to the worsening of
the cardiac function, vasoconstriction, and prognosis in CHF
patients (5, 8). The sustained increase in sympathetic nerve
activity in CHF is a complex issue and still little understood.
Previous studies have shown that the sympathetic exacerbation
involves alterations in the central nervous system and periph-
eral autonomic reflex control, including arterial baroreflex
(ABR) control (19, 38, 39). ABR control is a primary and
powerful inhibitory reflex of sympathetic nervous traffic during
short-term variation of arterial pressure (23, 38). The effective-
ness of the ABR control depends on the magnitude (gain) and
latency (time delay) of the effectors’ response (33, 35). Obser-
vational study shows that an ABR control gain of less than 3.0
ms/mmHg increases the risk of cardiac mortality in CHF
patients twofold (19), which is suggestive of powerful prog-
nostic information in this variable.
Previous studies have shown that exercise training plays a
remarkable role in CHF. Exercise training improves exercise
tolerance and quality of life in CHF patients (11, 29). This
amelioration in clinical status has been attributed to an im-
provement in skeletal myopathy (4, 10). Exercise training
substantially reduces sympathetic nerve activity and, in conse-
quence, vasoconstriction (16, 29). This change in neurovascu-
lar favors decreasing in muscle pro-inflammation and oxidative
stress.
The reduction in sympathetic nerve activity as a result of
exercise training in CHF has been linked to an enhancement in
ABR control. Experimental studies in pacing-induced heart
failure rabbits demonstrated that exercise training significantly
increased ABR (21). Similarly, exercise training significantly
increased ABR control of renal sympathetic nerve activity in
the ischemic model of HF rats (27, 28). However, the effects of
exercise training on ABR control of sympathetic nerve activity
in humans with CHF are unknown.
In the present study, we tested the hypothesis that exercise
training would increase the ABR control of MSNA (ABRMSNA)
in patients with CHF.
METHODS
Study Population
The study was approved by Scientific Research Committee of the
Heart Institute (InCor) (SDC-4060/14/040) and Human Subject Pro-
tection Committee of the Clinical Hospital, University of Sao Paulo,
Medical School (Plataforma Brasil, 31757714.4.0000.0068), and reg-
istered at www.ClinicalTrials.gov (NCT02219451). Patients were
selected by database from randomized studies performed at the Unit
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of Cardiovascular Rehabilitation and Exercise Physiology of the Heart
Institute (InCor), Medical School, University of São Paulo.
Twenty-six CHF outpatients [age 30–70 years, Functional Class II
to III, New York Heart Association, left ventricular ejection fraction
(EF) 40%, and peak oxygen uptake (V˙ O2) 20 ml·kg1·min1,
selected from other randomized studies of the Unit of Cardiac Reha-
bilitation and Exercise Physiology, Heart Institute (InCor), Medical
School, University of São Paulo] were included in the study. The
exclusion criteria were recent myocardial infarction or unstable an-
gina (3 mo), CHF duration (3 mo), permanent pacemaker depen-
dence, atrial fibrillation, skeletal muscle abnormality (e.g., arthritis),
and participation in a regular exercise program. They were assigned to
two groups: untrained (n  13) and exercise-trained (n  13).
Measurements and Procedures
Echocardiography. All patients underwent echocardiography be-
fore and after the protocol period follow-up in accordance with
international standards (30). Left ventricular EF, end-diastolic volume
(EDV), and end-systolic volume (ESV) were determined from the
two-dimensional echocardiography by Simpson method (IE33,
Philips Medical Systems, Andover, MA).
Cardiopulmonary exercise testing. As previously described (16,
36), all patients underwent maximal exercise capacity assessed during
a maximal progressive exercise test on cycle ergometer (Ergoline,
Spirit 150, Bitz, Germany), using a ramp protocol with work rate
increments of 5–10 W every min until exhaustion. V˙ O2 and carbon
dioxide production were determined by means of gas exchange on a
breath-by-breath basis in a computerized system (model Vmax 229,
SensorMedics, Buena Vista, CA). Peak V˙ O2 was defined as the
maximum attained V˙ O2 at the end of the exercise period in which the
subject could no longer maintain the cycle ergometer velocity at 60
rpm. Anaerobic threshold was determined to occur at the breakpoint
between the increase in the carbon dioxide output and V˙ O2 or at the
point in which the ventilatory equivalent for oxygen and end-tidal
oxygen partial pressure curves reached their respective minimum
values and began to rise. Respiratory compensation was determined to
occur at the point at which ventilatory equivalent for carbon dioxide
was lowest before a systematic increase and when end-tidal carbon
dioxide partial pressure reaches a maximum value and begins to
decrease (31). Cardiopulmonary exercise testing was conducted at
baseline and after 4 mo of exercise training or untrained control
period.
Muscle sympathetic nerve activity. MSNA was recorded directly
from the peroneal nerve (multiunit postganglionic) using a tungsten
microelectrode by means of technique of microneurography as previ-
ously described (37). In brief, the neural signals were amplified by a
factor of 50,000 to 100,000 and band-passed filtered (700 to 2,000
Hz). For recordings and analysis, nerve activity was rectified and
integrated (time constant, 0.1 s) to obtain a mean voltage display.
Muscle sympathetic bursts were identified by visual inspection by the
principal investigator and by two other investigators (C. E. Negrao
and M. U. Rondon) blinded to the study protocol. MSNA were
expressed as burst frequency (bursts per min) and burst incidence
(bursts per 100 heart beats).
Arterial pressure, heart rate, and respiratory rate. Systolic, dia-
stolic, and mean arterial pressure was measured noninvasively with an
oscillometric beat-to-beat basis by a finger photoplethysmography
device (Finometer Pro, Finapress Medical Systems, Amsterdam, The
Netherlands). Heart rate (HR) was measured through ECG lead II, and
respiratory rate was measured with a piezoelectric thoracic belt
(model 1132, Pneumotrace II) placed around the upper abdomen.
Autonomic control. As previously described (22, 35), the beat-to-
beat variability of MSNA, systolic arterial pressure (SAP), and respi-
ratory activity were analyzed by an autoregressive frequency domain
approach. This procedure enables the automatic quantification of the
center frequency and the power of each component in absolute as well
as in normalized units (nu) in very low (VLF: 0.003 to 0.04), low-(LF:
0.04 to 0.15 Hz), and high-frequency (HF: 0.15 to 0.40 Hz) ranges.
Furthermore, the ratio of LF of MSNA (LFMSNA) and HF of
MSNA (HFMSNA) was calculated for estimation of the LFMSNA/
HFMSNA (22, 35).
Arterial baroreflex control. As previously described in detail (35),
the transfer function analysis, using the bivariate autoregressive iden-
tification procedure, allows evaluating ABR function of MSNA. This
procedure permits the measurement of gain, coherence (k2), and phase
shift () of transfer function between an input and an output signals.
The gain of the transfer function quantifies the intensity of the
response of the output signal (MSNA) per unit of spontaneous change
of the input signal (SAP), being expressed in arbitrary units per
millimeters of mercury (au/mmHg). The coherence measures the
strength of the linearity between the oscillations at the same frequency
band in both variability signals and was accepted when 0.5. The
phase shift quantifies the phase offset between the oscillations in both
variability signals (the SAP changes precede MSNA changes) and
was accepted when it was between 0 and - (radians) (35). The gain
value is considered as a spontaneous index of sensitivity of ABRMSNA
(35). The time delay of ABR, an index that quantifies the latency of
the baroreflex response, was calculated as previously described (35).
In brief, considering that the phase shift is the product between the
time delay and the angular frequency (	), the time delay of ABRMSNA
in the LF range was quantified according to the following equation:
time delay  LF/	LF, in which 	LF is equal to the product between
central frequency of LF band and 2
. The time delay was expressed
in seconds (35).
Exercise training. The exercise training protocol was conducted for
4 mo, as previously described (11, 16, 36). In brief, it consisted of
three 60-min exercise sessions/week. Each exercise session consisted
of 5-min stretching exercises, 30-min of cycling on an ergometer
bicycle in the first 15 days, and up to 40 min in the rest of the period,
10 min of local strengthening exercises, 5 min of cool down with
stretching exercises. The exercise intensity was established by heart
rate levels that corresponded to anaerobic threshold up to 10% below
the respiratory compensation point obtained in the cardiopulmonary
exercise test. During the exercise sessions, when a training effect was
observed, as indicated by a decrease by 8% to 10% in heart rate, the
bicycle work rate was increased by 0.25 or 0.5 kpm to return to the
target heart rate levels. Subjects underwent exercise training under
supervision at the Heart Institute. The untrained patients were in-
structed to avoid any regular exercise program but advised to maintain
their daily activities. The physical activity status was followed every
3–4 wk at the clinic examination. At the end of the study, the patients
randomized to the untrained group were invited and encouraged to
participate of exercise training program under supervision in the Heart
Institute (InCor), Medical School, University of São Paulo.
Experimental Protocol
The experimental protocol was performed in a quiet and thermo-
neutral room at approximately the same time of the day, and all the
subjects were instructed to not interrupt their cardiac medications. The
subject was placed in the supine position, and electrocardiogram
electrodes were placed on the chest and the cuffs for arterial pressure
measurement were placed on the left arm. After patient’s instrumen-
tation, the signals of MSNA, arterial pressure, heart rate, and respi-
ratory rate were registered with subjects in rest for a period of 10 min.
The study was conducted before and after 4 mo of exercise training or
follow-up, 24–48 h after the last exercise training session.
Statistical Analysis
The data are presented as means  SE. A Chi-square (2) test was
used to assess categorical data differences. The Kolmogorov-Smirnov
and Levene’s test were used to assess the normality of distribution and
homogeneity for each variable. Variables with normal distribution
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and homogeneity were used parametric tests. Student’s t-test for
unpaired data was only used to test the baseline differences
between groups. Two-way ANOVA for repeated measures was
used to verify the effects of exercise training or clinical follow-up.
In case of significant difference, Scheffé’s post hoc was employed.
Probability value of P  0.05 was considered statistically signif-
icant.
RESULTS
Pretraining Measurements
Before training was started, baseline characteristics of un-
trained (n  13) and exercise-trained (n  13) CHF patients
were taken and are shown in Tables 1 and 2. There were no
differences between groups in age, body mass index, gender,
functional class, etiology, medications, presence of hyperten-
sion, and diabetes (Table 1). In addition, there were no differ-
ences in left ventricular EDV and ESV, HR, arterial pressure,
and peak V˙ O2. However, left ventricular EF was lower in the
exercise-trained group (Table 2).
Before training was started, the untrained and exercise-
trained groups were similar in resting MSNA burst frequency
and burst incidence (Fig. 1). With regard to the LFMSNA,
HFMSNA, LFMSNA/HFMSNA, and LF and HF central frequency
(	), there were no differences between groups (Table 3). The
gain, time delay, k2, and  of the ABRMSNA were also similar
between groups (Table 3 and Fig. 2).
Table 1. Baseline characteristics in the untrained and
exercise-trained chronic heart failure patients
UT ET P
Age, yr 49  3 57  3 0.07
BMI, kg/m2 28  1 29  1 0.60
Gender
Male 10 (77%) 12 (92%) 0.28
Female 3 (23%) 1 (8%)
Functional Class
NYHA II 12 (92%) 10 (77%) 0.27
NYHA III 1 (8%) 3 (23%) 0.27
CHF etiology
Idiopathic 6 (46%) 3 (23%) 0.22
Ischemic 3 (23%) 7 (54%) 0.11
Hypertensive 2 (15%) 1 (8%) 0.54
Chagasic 2 (15%) 2 (15%) 1.00
Medications
-Blocker 13 (100%) 13 (100%) 1.00
ACEI/ARA 13 (100%) 13 (100%) 1.00
Diuretics 13 (100%) 13 (100%) 1.00
Anticoagulant 6 (46%) 5 (38%) 0.69
Digitalis 0 1 (8%) 0.30
Statins 5 (38%) 7 (54%) 0.43
Hypertension 6 (46%) 5 (38%) 0.69
Diabetes 1 (8%) 1 (8%) 1.00
Values are means  SE; n  13 patients. UT, untrained; ET, exercise-
trained; BMI, body mass index; NYHA, New York Heart Association; CHF,
chronic heart failure; ACEI/ARA, angiotensin-converting enzyme inhibitors/
angiotensin II receptor antagonist.
Table 2. Effect of exercise training on hemodynamic and
functional capacity in chronic heart failure patients
UT ET
Pre Post Pre Post
EF, % 31  1 35  2 25  1† 27  2
EDV, ml 67  1 64  1 73  3 72  3
ESV, ml 56  1 51  1 62  3 58  4
HR, beats/min 64 3 62  3 59  2 60  2
SAP, mmHg 129 5 133  6 124  4 124  4
DAP, mmHg 70 3 73  3 67  2 69  3
MAP, mmHg 91 4 94  5 88  3 89  3
Peak V˙ O2, ml·kg1·min1 18  1 19  1 17  1 20  1*
Values are means  SE. EF, left ventricular ejection fraction; EDV, left
ventricular end-diastolic volume; ESV, left ventricular end-systolic volume;
HR, heart rate; SAP, systolic arterial pressure; DAP, diastolic arterial pressure;
MAP, mean arterial pressure; V˙ O2, oxygen uptake. *P  0.05, within group
comparison; †P  0.05, between group comparison,.
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Fig. 1. Resting muscle sympathetic nerve activity (MSNA) frequency (A) and
incidence (B) before and after 4 mo follow-up in untrained (UT) and exercise-
trained (ET) chronic heart failure patients. Note that exercise training markedly
decreased MSNA frequency and incidence, whereas clinical follow-up alone
unchanged MSNA. *P  0.05, within group comparison.
Table 3. Effect of exercise training on sympathetic
modulation and baroreflex control in chronic heart failure
patients
UT ET
Pre Post Pre Post
LFabs, au2 43  6 46  6 30  8 58  9
LFnorm, nu 42  4 31  6 35  6 44  4
	 LF, Hz 0.10  0.01 0.09  0.01 0.10  0.01 0.09  0.01
HF abs, au2 62  11 108  21 93  37 76  13
HF norm, nu 58  4 69  6 65  6 56  4
	 HF, Hz 0.30  0.02 0.27  0.02 0.24  0.02 0.29  0.02
LFMSNA/HFMSNA 0.8  0.1 0.6  0.1 0.7  0.1 0.9  0.1
k2 SAP-MSNA 0.69  0.05 0.67  0.06 0.64  0.05 0.64  0.04
 SAP-MSNA, rad 2.0  0.2 2.5  0.1 1.8  0.2 1.5  0.2
Values are means  SE. LF, low frequency; HF, high frequency; ab,
absolute; au, arbitrary units; nu, normalized units; 	, central frequency;
LFMSNA/HFMSNA, oscillatory pattern of muscle sympathetic nerve activity; k2,
coherence; SAP, systolic arterial pressure; , phase shift.
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Effects of Exercise Training
Exercise training caused no change in left ventricular EF,
EDV and ESV, HR, and arterial blood pressure (Table 2).
Exercise training significantly increased peak V˙ O2 (Table 2).
No changes were observed in the untrained group (Table
2). Exercise training significantly reduced resting MSNA
burst frequency and burst incidence (Fig. 1). In contrast, no
significant changes were found in the untrained group (Fig.
1). Exercise training did not change absolute or normalized
LFMSNA and LF central frequency or absolute or normalized
HFMSNA and HF central frequency. Exercise training tended to
reduce LFMSNA/HFMSNA (P  0.08, Table 3). In the untrained
group, no significant changes were observed in absolute and
normalized LFMSNA and absolute and normalized HFMSNA, and
LFMSNA/HFMSNA (Table 3).
With regard to arterial baroreflex control, the gain and time
delay (response) of the ABRMSNA were unchanged in exercise-
trained patients (Fig. 2). In contrast, in the untrained patients,
the gain of the ABRMSNA was significantly reduced and the
time delay (response) of the ABRMSNA was significantly in-
creased (Fig. 2). Thus the gain of the ABRMSNA was signifi-
cantly lower and the time delay (response) was significantly
higher in untrained patients compared with exercise-trained
patients (Fig. 2). No significant changes in k2 and  of the
ABRMSNA were observed in untrained patients and exercise-
trained patients (Table 3). Examples of individual raw data of
arterial pressure, sympathetic neurogram, and cross-spectral
analysis (gain, k2, and ) between MSNA and SAP variabili-
ties in one untrained patient and one exercise-trained patient
are displayed in Fig. 3.
DISCUSSION
The major and new finding of the present study is that
exercise training prevents the reduction in the gain and the
increase in the time delay of the ABRMSNA in CHF patients.
Since an impaired baroreflex control portends a worse prog-
nosis in heart failure, these findings may have implications for
improved overall survival in patients with CHF following
exercise training.
ABR control modulates sympathetic nerve activity at rest
and in response to acute changes in blood pressure (14, 18).
This autonomic control that originates in the carotid sinus and
aortic arch travels through the glossopharyngeal and vagal
nerves to the central nervous system (34, 38) and inhibits
efferent sympathetic nerve activity during acute increases of
blood pressure (26). Conversely, during a fall in blood pres-
sure, this inhibitory influence is acutely withdrawn. At rest the
ABR exerts a tonic inhibitory effect on resting MSNA. The
efficiency of the ABR depends on the magnitude (gain) and
latency (time delay) of the arterial baroreceptors response (7).
The ABR is impaired in chronic systolic CHF (15, 17), ex-
plaining, at least in part, the increased resting sympathetic
nerve activity in heart failure. In the present study, the ABRMSNA was
significantly decreased over time in the untrained group, de-
spite no apparent worsening in cardiac disease. This mismatch
between ABRMSNA and clinical status raises the possibility that
the deterioration in baroreflex control precedes the changes in
clinical status. Exercise training prevents the deterioration in
the ABRMSNA. ABRMSNA was unchanged in exercise-trained
patients over time. In the animal model of heart failure,
exercise training has been shown to improve ABR sensitivity
(20, 21).
Another interesting piece of information in the present study
was the fact that exercise training reduced resting MSNA.
These findings suggest that the reduction in sympathetic nerve
activity after exercise training in CHF patients is not only
mediated by increase in ABR sensitivity but may also be
modulated by chemoreflex control and/or ergoreflex control.
Exercise training normalizes renal sympathetic nerve activity
responses during variation of oxygen partial pressure (32). In a
recent study, we found that exercise training improved
mechano and metaboreflex control of MSNA in patients with
CHF (3). To our knowledge, this is the first demonstration that
exercise training prevents the reduction in ABRMSNA function
in CHF patients.
The effect of the exercise training on the sympathetic nerve
activity in humans with CHF has been extensively replicated.
Exercise training decreases MSNA regardless of age, gender,
and -blockers (1, 2, 16). The present study confirms these
previous findings. Our paradigm significantly reduced MSNA
in patients with CHF. These findings have clinical implica-
tions, since MSNA is an independent predictor of mortality in
patients with CHF (5).
The present study provides no information regarding the
mechanisms by which exercise training preserved ABRMSNA in
CHF patients. However, it is reasonable to suspect that exercise
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Fig. 2. Arterial baroreflex control of muscle sympathetic nerve activity
(ABRMSNA) in untrained (UT) and exercise-trained (ET) chronic heart failure
patients. Note that both, the gain (A) and time delay (response; B) of the arterial
baroreflex control were unchanged in ET patients. In contrast, in the UT
patients, the gain of the arterial baroreflex control was significantly reduced,
whereas the time delay (response) of the arterial baroreflex control was
significantly increased. SAP, systolic arterial pressure. *P  0.05, within
group comparison; † P  0.05, between groups comparison.
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training preserved endothelial function and arterial stiffness.
Reduction in arterial compliance (6, 13), which impairs the
efficiency of arterial baroreceptors to translate the spontaneous
oscillations in arterial pressure in CHF, is enhanced by exercise
training (9, 12). We cannot exclude the central component of
baroreflex pathway. Exercise training normalizes central an-
giotensin II concentration and angiotensin II type 1 receptor
messenger RNA (20). In addition, exercise training decreased
messenger RNA and protein expression of angiotensin II type
I receptors in the rostral ventrolateral medulla in heart failure
rabbits (24). This information is not available in our study.
However, we can speculate that exercise training prevented the
burden in the central nervous system caused by CHF.
Limitations
The baseline difference in left ventricular EF between
groups might suggest that we were dealing with patients in
different stages of cardiac dysfunction. This seems unlikely
because left ventricular EF was not the only criteria to select
patients to the study. Medications and peak V˙ O2 were not
different between untrained and exercise-trained patients,
which strengthen the clinical similarity between groups. In
addition, exercise training or clinical follow-up did not affect
left ventricular EF. In contrast, an increase in peak V˙ O2 and
preservation of ABRMSNA were only observed in the exercise-
trained patients.
Perspectives
The preservation of ABR sensitivity by exercise training is
an important finding and has clinical implications. ABR con-
trol has been associated with increased risk of cardiac death in
CHF patients (19). Since deterioration in ABR control takes
place even in a short period (16 wk), early initiation and
continuous maintenance of an exercise training program in
CHF patients is of paramount importance.
In conclusion, exercise training preserves the deterioration
in the ABRMSNA function in CHF patients.
Fig. 3. Examples of individual raw data of arterial
pressure, sympathetic neurogram, and cross-spectral
analysis [gain of the arterial baroreflex control, solid
black line; coherence (K2), dotted black line; phase shift
(), solid gray line; and central frequency of peak
coherence (closed circle) with the respective phase shift
and gain of the arterial baroreflex control] between
MSNA and SAP variability in one UT (A) and one ET
(B) chronic heart failure (CHF) patient. Note that exer-
cise training decreased MSNA. In addition, exercise
training prevents the reduction in the gain of the ABRMSNA.
In contrast, the gain of the ABRMSNA decreased in the
UT patient. au, arbitrary unis; rad, radians.
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